Nasopharyngeal carcinoma staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
(8 intermediate revisions by one other user not shown) | |||
Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
[[ | The staging of [[nasopharyngeal carcinoma]] is based on the [[TNM]] staging system. | ||
==Staging== | ==Staging== | ||
The staging of [[nasopharyngeal carcinoma]] is based on the TNM staging system. | |||
==TNM staging== | ==TNM staging== | ||
===Primary tumor=== | ===Primary tumor=== | ||
Line 15: | Line 16: | ||
**T2a: without extension to the parapharyngeal region | **T2a: without extension to the parapharyngeal region | ||
**T2b: with extension to the parapharyngeal region | **T2b: with extension to the parapharyngeal region | ||
*T3: invasion of adjacent bony structures and/or paranasal sinuses | *T3: invasion of adjacent bony structures and/or [[paranasal sinuses]] | ||
*T4: invasion of any one or more of the following | *T4: invasion of any one or more of the following | ||
**intracranial content | **[[intracranial]] content | ||
**[[cranial]] | **[[cranial nerve]]s | ||
**[[infratemporal]] fossa/masticator space | **[[infratemporal]] fossa/masticator space | ||
**[[hypopharynx]] | **[[hypopharynx]] | ||
**orbit | **[[orbit]] | ||
===Nodal status=== | ===Nodal status=== | ||
*Nx: nodes cannot be assessed | *Nx: nodes cannot be assessed | ||
*N0: no evidence of nodal involvement | *N0: no evidence of nodal involvement | ||
*N1: unilateral nodal involvement <6cm maximal diameter above | *N1: unilateral nodal involvement <6cm maximal diameter above supraclavicular fossa | ||
*N2: bilateral nodal involvement <6cm maximal diameter above | *N2: bilateral nodal involvement <6cm maximal diameter above [[supraclavicular fossa]] | ||
*N3 | *N3 | ||
**N3a: >6 cm maximal diameter (unilateral or bilateral) | **N3a: >6 cm maximal diameter (unilateral or bilateral) | ||
**N3b: involvement of the | **N3b: involvement of the supraclavicular fossa | ||
===Metastases=== | ===Metastases=== | ||
*Mx: presence of metastases cannot be assessed | *Mx: presence of metastases cannot be assessed | ||
*M0: no evidence of metastases | *M0: no evidence of metastases | ||
*M1: distant metastases present | *M1: distant metastases present | ||
===Stage | ===Stages of Nasopharyngeal carcinoma=== | ||
{| {{table}} | |||
! style="background: #4479BA;" | {{fontcolor|#FFF|'''Stage'''}} | |||
! style="background: #4479BA;" | {{fontcolor|#FFF|'''T'''}} | |||
! style="background: #4479BA;" | {{fontcolor|#FFF|'''N'''}} | |||
! style="background: #4479BA;" | {{fontcolor|#FFF|'''M'''}} | |||
|- | |||
| 0 ||Tis ||N0 ||M0 | |||
|- | |||
| I ||T1 ||N0 ||M0 | |||
|- | |||
| II ||T2a ||N0 ||M0 | |||
|- | |||
| II ||T2b ||N0 ||M0 | |||
|- | |||
|III ||T3 ||N0 ||M0 | |||
|- | |||
| ||T1 ||N1 ||M0 | |||
|- | |||
| || T2||N1 || M0 | |||
|- | |||
| ||T3||N1||M0 | |||
|- | |||
|IVA||T4a||N0||M0 | |||
|- | |||
| ||T4a||N1||M0 | |||
|- | |||
| ||T1 ||N2||M0 | |||
|- | |||
| ||T2 ||N2||M0 | |||
|- | |||
| ||T3 ||N2||M0 | |||
|- | |||
| ||T4a||N2||M0 | |||
|- | |||
|IVB||AnyT ||N3||M0 | |||
|- | |||
| ||T4b||AnyN ||M0 | |||
|- | |||
|IVC||AnyT ||AnyN||M1 | |||
|} | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Line 51: | Line 88: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Otolaryngology]] |
Latest revision as of 02:57, 27 November 2017
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma staging On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma staging |
Risk calculators and risk factors for Nasopharyngeal carcinoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
The staging of nasopharyngeal carcinoma is based on the TNM staging system.
Staging
The staging of nasopharyngeal carcinoma is based on the TNM staging system.
TNM staging
Primary tumor
- Tx: primary tumor cannot be assessed
- T0: no evidence of primary tumor
- Tis: carcinoma in situ
- T1: tumor is confined to the nasopharynx
- T2: tumor extends to soft tissues of the oropharynx and/or nasal fossa
- T2a: without extension to the parapharyngeal region
- T2b: with extension to the parapharyngeal region
- T3: invasion of adjacent bony structures and/or paranasal sinuses
- T4: invasion of any one or more of the following
- intracranial content
- cranial nerves
- infratemporal fossa/masticator space
- hypopharynx
- orbit
Nodal status
- Nx: nodes cannot be assessed
- N0: no evidence of nodal involvement
- N1: unilateral nodal involvement <6cm maximal diameter above supraclavicular fossa
- N2: bilateral nodal involvement <6cm maximal diameter above supraclavicular fossa
- N3
- N3a: >6 cm maximal diameter (unilateral or bilateral)
- N3b: involvement of the supraclavicular fossa
Metastases
- Mx: presence of metastases cannot be assessed
- M0: no evidence of metastases
- M1: distant metastases present
Stages of Nasopharyngeal carcinoma
Stage | T | N | M |
---|---|---|---|
0 | Tis | N0 | M0 |
I | T1 | N0 | M0 |
II | T2a | N0 | M0 |
II | T2b | N0 | M0 |
III | T3 | N0 | M0 |
T1 | N1 | M0 | |
T2 | N1 | M0 | |
T3 | N1 | M0 | |
IVA | T4a | N0 | M0 |
T4a | N1 | M0 | |
T1 | N2 | M0 | |
T2 | N2 | M0 | |
T3 | N2 | M0 | |
T4a | N2 | M0 | |
IVB | AnyT | N3 | M0 |
T4b | AnyN | M0 | |
IVC | AnyT | AnyN | M1 |